cytotoxic t-lymphocytes

DRUG2 trials

Sponsors

New York Medical College

Conditions

AdenovirusEpstein-Barr Virus InfectionsPrimary Immune Deficiency Disorder

Phase 2

EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection

RecruitingNCT03266653

New York Medical CollegeEpstein-Barr Virus Infections, Primary Immune Deficiency Disorder

Start: 2020-07-07End: 2027-12-31Target: 20Updated: 2025-08-08

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

RecruitingNCT03266627

New York Medical CollegeAdenovirus, Primary Immune Deficiency Disorder

Start: 2018-11-01End: 2027-12-31Target: 20Updated: 2025-08-08